BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37472791)

  • 1. Ovarian Tumors.
    Byford WH
    Chic Med Exam; 1862 Feb; 3(2):65-88. PubMed ID: 37472791
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative cytogenetic studies of benign, borderline, and malignant epithelial ovarian tumors.
    Izutsu T; Kudo T; Shoji T; Nishiya I
    J Obstet Gynaecol Res; 1996 Dec; 22(6):541-9. PubMed ID: 9037943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucinous Ovarian Tumors.
    Mills AM; Shanes ED
    Surg Pathol Clin; 2019 Jun; 12(2):565-585. PubMed ID: 31097115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial membrane protein 1 expression in ovarian serous tumors.
    Demirag GG; Kefeli M; Kemal Y; Yucel I
    Oncol Lett; 2016 Mar; 11(3):2140-2144. PubMed ID: 26998138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CEA determination in aspired fluid of cystic ovarian tumors and ovarian cysts and in ascites and serum samples of patients with ovarian tumors].
    Kunze M; Büttner HH; Strache RR; Voss P; Briese V; Schrodt U
    Zentralbl Gynakol; 1988; 110(16):1006-12. PubMed ID: 3188713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging in pediatric ovarian tumors.
    Hanafy AK; Mujtaba B; Yedururi S; Jensen CT; Sanchez R; Austin MT; Morani AC
    Abdom Radiol (NY); 2020 Feb; 45(2):520-536. PubMed ID: 31745573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiology of Ascites and Pleural Effusion Associated with Ovarian Tumors: Literature Review and Case Reports of Three Ovarian Tumors Presenting with Massive Ascites, but without Peritoneal Dissemination.
    Miyoshi A; Miyatake T; Hara T; Tanaka A; Komura N; Komiya S; Kanao S; Takeda M; Mimura M; Nagamatsu M; Yokoi T
    Case Rep Obstet Gynecol; 2015; 2015():414019. PubMed ID: 26858849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Preoperative Differential Diagnosis of Benign, Borderline, and Malignant Ovarian Tumors.
    Yun TH; Jeong YY; Lee SJ; Choi YS; Ryu JM
    J Clin Med; 2022 Mar; 11(5):. PubMed ID: 35268446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative evaluation of ovarian tumors in the premenopause by transvaginosonography.
    Osmers RG; Osmers M; von Maydell B; Wagner B; Kuhn W
    Am J Obstet Gynecol; 1996 Aug; 175(2):428-34. PubMed ID: 8765264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of c-Kit and PDGFRα in epithelial ovarian tumors and tumor stroma.
    Yi C; Li L; Chen K; Lin S; Liu X
    Oncol Lett; 2012 Feb; 3(2):369-372. PubMed ID: 22740913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of microsatellite instability in sporadic epithelial ovarian tumors.
    Yoon BS; Kim YT; Kim JH; Kim SW; Nam EJ; Cho NH; Kim JW; Kim S
    Yonsei Med J; 2008 Apr; 49(2):272-8. PubMed ID: 18452265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CyclinD1 copy number changes with histological type in ovarian tumors.
    Dimova I; Zaharieva B; Raicheva S; Milev I; Dimitrov R; Doganov N; Aleksandrov M; Todorov T; Toncheva D
    Acta Oncol; 2004; 43(7):675-9. PubMed ID: 15545188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathologic Patterns of Ovarian Tumors in Hawassa University Comprehensive Specialized Hospital, Southern Ethiopia.
    Abena TA; Yerakly F; Korga T
    J Oncol; 2023; 2023():2803201. PubMed ID: 37744161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors.
    Berchuck A; Kohler MF; Hopkins MP; Humphrey PA; Robboy SJ; Rodriguez GC; Soper JT; Clarke-Pearson DL; Bast RC
    Gynecol Oncol; 1994 Feb; 52(2):232-6. PubMed ID: 7508877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological pattern of ovarian tumors and their age distribution.
    Jha R; Karki S
    Nepal Med Coll J; 2008 Jun; 10(2):81-5. PubMed ID: 18828427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic challenge of secondary (metastatic) ovarian tumors simulating primary endometrioid and mucinous neoplasms.
    Hart WR
    Pathol Int; 2005 May; 55(5):231-43. PubMed ID: 15871720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspiration cytology and E2 content in ovarian tumors.
    Geier GR; Strecker JR
    Acta Cytol; 1981; 25(4):400-6. PubMed ID: 6945006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for laparoscopic surgery of ovarian tumors.
    Konno R; Nagase S; Sato S; Fukaya T; Yajima A
    Tohoku J Exp Med; 1996 Mar; 178(3):225-31. PubMed ID: 8727704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of Benign Brenner Tumor with Mucinous Cystadenoma in an Ovarian Mass.
    Nazari F; Dehghani Z
    Iran J Pathol; 2020; 15(4):334-337. PubMed ID: 32944047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral Blood Serum NMR Metabolomics Is a Powerful Tool to Discriminate Benign and Malignant Ovarian Tumors.
    Nunes SC; Sousa J; Silva F; Silveira M; Guimarães A; Serpa J; Félix A; Gonçalves LG
    Metabolites; 2023 Sep; 13(9):. PubMed ID: 37755269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.